Press ReleasesRead more
OncoBay Story & Mission
OncoBay Clinical is a boutique CRO specializing in immuno-oncology/cell therapy, offering full- service custom-curated CRO solutions for global pharmaceutical and biotech companies looking to advance their immuno-oncology product or device.
As a wholly-owned, for-profit subsidiary of Moffitt Cancer Center, OncoBay embeds scientific expertise, operational excellence, and integrated cell manufacturing capabilities providing true end-to-end control. Built on a cellular therapy focus, a streamlined technology framework, a highly trained site network, and a dedicated team of experienced professionals, OncoBay is committed to operational excellence from start to finish.
To support drug developers and physicians in discovering the cure for cancer.
To transform IO research through innovation, collaboration and partnership to positively impact cancer patients’ lives.